Virtus Investment Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Virtus Investment Advisers's BMY Position: Q3 2023 in Review
Virtus Investment Advisers sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 2,148 shares — an estimated $137K sold.
Virtus Investment Advisers first reported a position in BMY in Q3 2016 and held it in 9 quarters. The position peaked at $3M in Q3 2016. 2,389 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- Virtus Investment Advisers reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
- Virtus Investment Advisers sold 2,148 Bristol-Myers Squibb shares in Q3 2023, an estimated $137K.
- Virtus Investment Advisers first reported a position in Bristol-Myers Squibb in Q3 2016 and held it in 9 quarters.
- Virtus Investment Advisers's Bristol-Myers Squibb position peaked at $3M in Q3 2016.
- 2,389 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on Virtus Investment Advisers's 13F filing for Q3 2023, filed 8 Nov 2023.